Relationship of Adiponectin and Insulin Resistance in Patients with Chronic Kidney Disease
10.3969/j.issn.0253-9896.2013.07.001
- VernacularTitle:慢性肾脏病非透析患者血尿脂联素与胰岛素抵抗的变化及相互关系*
- Author:
Yan YU
;
Yaping FAN
;
Lan SHI
- Publication Type:Journal Article
- Keywords:
kidney diseases;
adiponectin;
insulin resistance;
lipids;
serum albumin;
hemoglobin;
urinary protein
- From:
Tianjin Medical Journal
2013;(7):625-627
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the changes of serum and urinary adiponectin (ADPN) levels and insulin resis-tance (IR) states in patients with chronic kidney disease (CKD), and to explore their relationship thereof. Methods A total of 487 patients with CKD stages 2-5 were enrolled in this study, and 30 healthy subjects were served as control group. The se-rum ADPN levels in urine samples were examined by ELISA. The level of fasting insulin (FINS) was detected by radioimmu-noassay. Blood routine test, liver and kidney functions, blood glucose, serum lipids, 24 h urinary protein excretion and endoge-nous creatinine clearance rate (Ccr) and body mass index (BMI) were observed and calculated. The differences of ADPN lev-els in serum and urine samples and homeostasis model assessment for insulin resistance (Homa-IR) were compared between groups. Results The serum and urine ADPN levels and Homa-IR were higher in CKD patients than those of controls (P＜0.05). With the decline in renal function, the ADPN and Homa-IR levels were increased gradually (P＜0.05). The value of se-rum ADPN was significantly higher in patients with CKD stages 3-5 and high Homa-IR. The ADPN levels and Homa-IR were positively related to lipid parameters and 24 h urinary protein, and negatively correlated with hemoglobin and serum al-bumin in patients with CKD (P ＜ 0.05). Conclusion CKD patients had higher ADPN level and more significant IR. The ADPN and IR were correlated with serum lipids, hemoglobin, albumin and urinary protein. Dynamic monitor of ADPN level may have clinical significance in judging metabolic disorders in CKD patients.
